Association of RNA helicase a with human immunodeficiency virus type 1 particles

被引:86
|
作者
Roy, BB
Hu, J
Guo, XF
Russell, RS
Guo, F
Kleiman, L
Liang, C
机构
[1] Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
关键词
D O I
10.1074/jbc.M510596200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA helicase A (RHA) belongs to the DEAH family of proteins that are capable of unwinding double-stranded RNA structure. In addition to its involvement in the metabolism of cellular RNA, RHA has been shown to stimulate RNA transcription from the long terminal repeat promoter of human immunodeficiency virus type 1 (HIV-1) as well as to enhance Rev/Rev response element-mediated gene expression. In this study, we provide evidence that RHA associates with HIV-1 Gag in an RNA-dependent manner. This interaction results in specific incorporation of RHA into HIV-1 particles. Knockdown of endogenous RHA in virus producer cells leads to generation of HIV-1 particles that are less infectious in part as a result of restricted reverse transcription. Therefore, RHA represents the first example of cellular RNA helicases that participate in HIV-1 particle production and promote viral reverse transcription.
引用
收藏
页码:12625 / 12635
页数:11
相关论文
共 50 条
  • [21] Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
    Gorny, MK
    Stamatatos, L
    Volsky, B
    Revesz, K
    Williams, C
    Wang, XH
    Cohen, S
    Staudinger, R
    Zolla-Pazner, S
    JOURNAL OF VIROLOGY, 2005, 79 (08) : 5232 - 5237
  • [22] In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles
    Morikawa, Y
    Shibuya, M
    Goto, T
    Sano, K
    VIROLOGY, 2000, 272 (02) : 366 - 374
  • [23] A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1
    Fujii, R
    Okamoto, M
    Aratani, S
    Oishi, T
    Ohshima, T
    Taira, K
    Baba, M
    Fukamizu, A
    Nakajima, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) : 5445 - 5451
  • [24] Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles
    Wang, Xin
    Li, Xiaoyu
    Ma, Jing
    Zhang, Li
    Ma, Ling
    Mi, Zeyun
    Zhou, Jinming
    Guo, Fei
    Kleiman, Lawrence
    Cen, Shan
    VIRUS RESEARCH, 2014, 191 : 30 - 38
  • [25] Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes
    Khan, MA
    Kao, S
    Miyagi, E
    Takeuchi, H
    Goila-Gaur, R
    Opi, S
    Gipson, CL
    Parslow, TG
    Ly, H
    Strebel, K
    JOURNAL OF VIROLOGY, 2005, 79 (09) : 5870 - 5874
  • [26] Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection
    Coombs, RW
    Welles, SL
    Hooper, C
    Reichelderfer, PS
    DAquila, RT
    Japour, AJ
    Johnson, VA
    Kuritzkes, DR
    Richman, DD
    Kwok, S
    Todd, J
    Jackson, JB
    DeGruttola, V
    Crumpacker, CS
    Kahn, J
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 704 - 712
  • [27] APOBEC3G incorporation into human immunodeficiency virus type 1 particles
    Zennou, W
    Perez-Caballero, D
    Göttlinger, H
    Bieniasz, PD
    JOURNAL OF VIROLOGY, 2004, 78 (21) : 12058 - 12061
  • [28] Detection and quantitation of human immunodeficiency virus type-1 particles by confocal microscopy
    Bhattacharya, B
    Weiss, RA
    Davis, C
    Holmes, H
    Hockley, D
    Fassati, A
    JOURNAL OF VIROLOGICAL METHODS, 2004, 120 (01) : 13 - 21
  • [29] Covalent bonded Gag multimers in human immunodeficiency virus type-1 particles
    Kitagawa, Yoshinori
    Maeda-Sato, Masae
    Tanaka, Keiko
    Tobiume, Minoru
    Sawa, Hirofumi
    Hasegawa, Hideki
    Kojima, Asato
    Hall, William W.
    Kurata, Takeshi
    Sata, Tetsutaro
    Takahashi, Hidehiro
    MICROBIOLOGY AND IMMUNOLOGY, 2009, 53 (11) : 609 - 620
  • [30] Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA
    P Konstantinova
    W de Vries
    J Haasnoot
    O ter Brake
    P de Haan
    B Berkhout
    Gene Therapy, 2006, 13 : 1403 - 1413